Concerns raised last year over drug price deal delay
Exchequer unlikely to see any reprieve on prices until second half of 2016
The Department of Public Expenditure and Reform flagged concerns about delays in progressing a medicine price deal with big pharma a year ago.
The existing price deal that governs prices for the HSE’s €2 billion-plus spend on medicines was negotiated in 2012. With formal negotiations on a new deal yet to start, the exchequer is unlikely to see any reprieve on prices until the second half of 2016.
In a letter obtained under ...
